Tamara Taggart, PhD, MPH
Assistant Professor Adjunct of Public Health (Social & Behavioral Sciences)Cards
About
Research
Publications
2024
Identifying facilitators and barriers to the uptake of medication for opioid use disorder in Washington, DC: A community-engaged concept mapping approach
Gullahorn B, Kuo I, Robinson A, Bailey J, Loken J, Taggart T. Identifying facilitators and barriers to the uptake of medication for opioid use disorder in Washington, DC: A community-engaged concept mapping approach. PLOS ONE 2024, 19: e0306931. PMID: 39028730, PMCID: PMC11259286, DOI: 10.1371/journal.pone.0306931.Peer-Reviewed Original ResearchConceptsConcept mapping approachOpioid use disorderUptake of medicationCommunity advisory boardStigma associated with substance useUse disorderPublic health challengeAwareness of treatmentMOUD deliverySense of hopelessnessIdentified barriersUnique statementsHealth challengesAdvisory boardOpioid overdoseProvidersCommunity membersMOUD engagementMOUDSubstance useTreatment programsHopelessnessMedicationPersonal motivationFacilitationReligion, Spirituality, and COVID-19
Ransome Y, Taggart T, Kawachi I. Religion, Spirituality, and COVID-19. 2024, 395-419. DOI: 10.1093/oso/9780197625217.003.0016.Peer-Reviewed Original ResearchReligious service attendanceService attendanceLevels of religious service attendanceConstructs of religiosityReading scriptureReligious textsReligious practicesPrivate religiosityReligious effectsSpecific traditionsReligionReligiositySocial relationsCOVID-19 health outcomesEucharistScriptureCommunionGoodsSpiritualityTraditionRitualsMeditationOrganizational aspectsTextPurview
2023
1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers
Davis W, Mantsios A, Metzner A, Talan A, Kwait J, Rodriguez H, Karver T, Barker S, Suarez A, Fernandez R, Rodriguez-Diaz C, Taggart T, Oglesby A, Garris C, Wohl D, Barrington C, Kerrigan D. 1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers. Open Forum Infectious Diseases 2023, 10: ofad500.1371. PMCID: PMC10677220, DOI: 10.1093/ofid/ofad500.1371.Peer-Reviewed Original ResearchPre-exposure prophylaxisHealthcare providersLA PrEPInjectable pre-exposure prophylaxisHIV pre-exposure prophylaxisExit interviewsPrEP conversationsClinic visitsPrEP knowledgePrEP useClinical visitsViiV HealthcarePrEP usersHIV preventionSide effectsFDA approvalCare optionsPrEPAcceptable deliveryKnowledge deficitsFormative researchProphylaxisVisitsMinor suggestionsDiverse populations1843. Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors
Kerrigan D, Yonamine K, O’Rourke A, Karver T, Davis W, Metzner A, Oglesby A, Garris C, Scott R, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y. 1843. Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors. Open Forum Infectious Diseases 2023, 10: ofad500.1671. PMCID: PMC10678848, DOI: 10.1093/ofid/ofad500.1671.Peer-Reviewed Original ResearchSocial structural factorsFemale sex workersCisgender womenDominican RepublicHIV pre-exposure prophylaxisUnited StatesLA PrEPSocial structural constraintsNew HIV infectionsReproductive health servicesGender normsHealthcare providersInjectable PrEPThematic content analysisPrEP uptakeDepth interviewsHIV infectionPartner dynamicsSex workersEmpowerment toolReproductive healthcare providersDisproportionate impactPre-exposure prophylaxisTransgender womenContent analysis